Fatal overdoses involving fentanyl mixed with stimulants among Americans 65 and older did not just rise in recent years, they skyrocketed. A new analysis of federal death records found those deaths climbed roughly 9,000% between 2015 and 2023, pulling older adults into what researchers are calling the fourth wave of the opioid crisis. The shift is forcing clinicians to rethink how they manage pain in seniors and is driving fresh calls for clearer medication reviews, better caregiver education and wider naloxone access for older patients.
The finding comes from an examination of 404,964 CDC death certificates presented at ANESTHESIOLOGY 2025, according to the American Society of Anesthesiologists. The researchers identified 17,040 fentanyl-related deaths among people 65 and older and reported that stimulant co-involvement rose from about 8.7% of fentanyl deaths in 2015 to roughly 49.9% in 2023. Local outlets picked up the alarming trend as well, including a WISH-TV health report that flagged the sharp jump.
How the spike unfolded
Coverage of the analysis highlights that annual fentanyl deaths among seniors increased from 264 in 2015 to 4,144 in 2023, a roughly 1,470% rise, while the share that involved stimulants climbed even faster, according to reporting by HealthDay. Investigators say the surge in stimulant co-involvement began to accelerate around 2020. Cocaine and methamphetamine were the most common stimulants found alongside fentanyl. Because many overdose deaths involve several substances, researchers stressed that the pattern reflects changes in the illicit drug supply as much as changes in individual behavior.
Why seniors are vulnerable
Clinicians point to age-related shifts that change how the body handles drugs. Older adults often have slower liver and kidney clearance, altered body composition and increased sensitivity to medications, all of which prolong drug effects and raise overdose risk, as outlined in a recent geriatric pharmacology review. On top of that, seniors are more likely to be taking multiple prescriptions at once, a scenario known as polypharmacy, which increases the chances of dangerous interactions. Those physiological and medication factors make even small or adulterated doses of fentanyl particularly hazardous for older patients.
What clinicians and families are being told
Professional groups and the study authors are urging extra caution for patients over 65. The American Society of Anesthesiologists advises that prescribers regularly reassess opioid treatment plans, simplify medication routines when possible and bring caregivers into conversations about naloxone education. Daniel Arendt, a pharmacist at the University of Cincinnati, emphasized the stakes in local coverage, saying that "the overdose crisis has continually gotten worse" and underscoring the need for naloxone availability, according to the university's newsroom. Families are being encouraged to review pill bottles, talk with clinicians about non-opioid options for pain and keep an opioid reversal medication on hand when there are known risk factors.
Where this fits in the national picture
All of this is unfolding as provisional data from the Centers for Disease Control and Prevention suggest that overall U.S. overdose deaths declined in 2024, even as synthetic opioids such as fentanyl remain central drivers of the crisis, according to a January NCHS brief. That report notes a substantial year-over-year drop in total deaths but also makes clear that fentanyl and other synthetic opioids still account for a large share of fatal overdoses. Public-health officials say the new analysis of senior deaths should be a warning sign that targeted outreach to older patients and their caregivers cannot wait.
For families and caregivers, the basic guidance is direct. Learn the signs of a possible opioid overdose, which can include very slow or stopped breathing, extreme drowsiness or unresponsiveness, pinpoint pupils and bluish lips or nails. Call 911 immediately, and if naloxone is available, use it. The FDA recommends that clinicians discuss naloxone whenever they prescribe opioid medicines and provides instructions on how patients can obtain and use the reversal drug, noting that it can restore breathing within minutes. Stay with the person, follow emergency operator directions and let first responders know that naloxone was given.
